Program Overview

Master in Silico Drug Design (RUS)

The Master in Silico Drug Design (RUS) is a double degree program offered in partnership with Sechenov University, Russia. This program focuses on the computational modeling of biological macromolecule targets and their interactions with drugs and other chemical molecules.

Program Overview

The program is aimed at students with a background in biology, biochemistry, bioinformatics, or the biomedical field, who wish to acquire in-depth knowledge in modeling therapeutic macromolecules. It includes participation by international experts and a semester of study and/or internship abroad.

Degrees Awarded

Upon completion of the program, students are awarded two degrees:

• Master degree in Bio-informatics in the specialty “In silico Drug Design – Macromolecule Modeling” from Université Paris Cité
• Master degree in “Information systems and technologies”, specialty “Computer modeling in pharmacology” from Sechenov University

Entry Requirements

To be eligible for the program, students must have a bachelor or equivalent degree in bioinformatics or chemistry (180 ECTS credits) with minimum knowledge in the field of informatics. Students with an equivalent degree in physical, biochemistry, pharmacy, chemical, physical, and mathematical sciences are also eligible, provided they pass the Université Paris Cité entrance examination.

Language Pre-requisites

Students must have a B2 level of French and English.

Course Overview

The “ISDD-Macromolecules” course focuses on the computational modeling of biological macromolecule targets and their interactions with drugs and other chemical molecules. This course trains professionals from the private and public sectors who are involved in research through in silico approaches in the field of therapeutic innovation.

Skills and Competencies Developed

The program develops the following skills and competencies:

• Research of bioactive compounds and research in preparation for further study at the doctoral level
• Training on how to navigate the chemical elements rationally in order to facilitate the discovery of bioactive molecules necessary for an understanding of Life and the prediction of the impact of xenobiotics on humans and the environment
• At the end of the Master’s, students should be able to participate or lead projects in silico drug design in pharmaceutical companies, medicinal chemistry companies, or among sellers of chemicals or specialized software.

Program Structure

As part of this double degree, Russian students will do their 1st year of master (S1+S2) at the University of Sechenov and S3 at Université Paris Cité. Students will spend their S4 doing their internship at the University of their choice (Paris or Sechenov). As part of the double degree, students from Paris will be able to do their semester 2 and/or their semester 4 internship at Sechenov University.

Note

Due to the current conflict, the university has currently suspended its agreements with the Russian partner universities. The pedagogical team consequently suspended its partnership with the University of Sechenov.